Evidence map›Paper›PMID 35561185›Full record

ArticleBioinformatics (Oxford, England)2022

Network-based cancer heterogeneity analysis incorporating multi-view of prior information.

Yang Li, Shaodong Xu, Shuangge Ma, Mengyun Wu

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yang LiCenter for Applied Statistics, School of Statistics, Statistical Consulting Center, and RSS and China-Re Life Joint Lab on Public Health and Risk Management, Renmin University of China, Beijing 100872, China.ORCID 0000-0002-6287-5094
Shaodong XuCenter for Applied Statistics, School of Statistics, Statistical Consulting Center, and RSS and China-Re Life Joint Lab on Public Health and Risk Management, Renmin University of China, Beijing 100872, China.
Shuangge MaDepartment of Biostatistics, Yale School of Public Health, New Haven, CT 06520, USA.ORCID 0000-0001-9001-4999
Mengyun WuSchool of Statistics and Management, Shanghai University of Finance and Economics, Shanghai 200433, China.ORCID 0000-0002-0970-4712

Funding

Novel methods for identifying genetic interactions in cancer prognosisR01CA204120 · NCI · YALE UNIVERSITY · PI Shuangge Ma · 2016 to 2026
$3.5M
NCI NIH HHS R01 CA204120
6 · The paper itself

Abstract

motivationCancer genetic heterogeneity analysis has critical implications for tumour classification, response to therapy and choice of biomarkers to guide personalized cancer medicine. However, existing heterogeneity analysis based solely on molecular profiling data usually suffers from a lack of information and has limited effectiveness. Many biomedical and life sciences databases have accumulated a substantial volume of meaningful biological information. They can provide additional information beyond molecular profiling data, yet pose challenges arising from potential noise and uncertainty.

resultsIn this study, we aim to develop a more effective heterogeneity analysis method with the help of prior information. A network-based penalization technique is proposed to innovatively incorporate a multi-view of prior information from multiple databases, which accommodates heterogeneity attributed to both differential genes and gene relationships. To account for the fact that the prior information might not be fully credible, we propose a weighted strategy, where the weight is determined dependent on the data and can ensure that the present model is not excessively disturbed by incorrect information. Simulation and analysis of The Cancer Genome Atlas glioblastoma multiforme data demonstrate the practical applicability of the proposed method. AVAILABILITY AND IMPLEMENTATION: R code implementing the proposed method is available at https://github.com/mengyunwu2020/PECM. The data that support the findings in this paper are openly available in TCGA (The Cancer Genome Atlas) at https://portal.gdc.cancer.gov/. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

Indexed as

GlioblastomaSoftwareComputer SimulationGenomeHumansPrecision Medicine

Identifiers

PMID35561185
PMCPMC9113254

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.